Antioxidant therapy to improve or resolve atherosclerosis; new hopes and current trends

Banafsheh Yalameha *

Cited by CrossRef: 6

1- Khoshbin M, Ahmadi S, Cheraghi M, Nouryazdan N, Birjandi M, Shahsavari G. Association of E-Selectin gene polymorphisms and serum E-Selectin level with risk of coronary artery disease in lur population of Iran. Archives of Physiology and Biochemistry. 2023;129(2):387 [Crossref]

2- Marino M, Vairo G, Wriggers P. Mechano-chemo-biological Computational Models for Arteries in Health, Disease and Healing: From Tissue Remodelling to Drug-eluting Devices. CPD. 2021;27(16):1904 [Crossref]

3- Sharif H, Akash M, Rehman K, Irshad K, Imran I. Pathophysiology of atherosclerosis: Association of risk factors and treatment strategies using plant‐based bioactive compounds. J Food Biochem. 2020;44(11) [Crossref]

4- Asbaghi O, Moradi S, Kashkooli S, Zobeiri M, Nezamoleslami S, Hojjati Kermani M, Lazaridi A, Miraghajani M. The effects of oral magnesium supplementation on glycaemic control in patients with type 2 diabetes: a systematic review and dose–response meta-analysis of controlled clinical trials. Br J Nutr. 2022;128(12):2363 [Crossref]

5- Yalameha B, Birjandi M, Nouryazdan N, Nasri H, Shahsavari G. Association between the FABP2 Ala54Thr and CRP+1059C/G polymorphisms and small dense LDL level in patients with atherosclerosis: a case–control study. Archives of Physiology and Biochemistry. 2023;129(1):246 [Crossref]

6- Yalameha B, Nejabati H, Nouri M. Cardioprotective potential of vanillic acid. Clin Exp Pharma Physio. 2023;50(3):193 [Crossref]